Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
The human breast cancer resistance protein (BCRP/ABCG2) is the second member of the G subfamily of the large ATPbinding cassette (ABC) transporter superfamily. BCRP was initially discovered in multidrug resistant breast cancer cell lines where it confers resistance to chemotherapeutic agents such as mitoxantrone, topotecan and methotrexate by extruding these compounds out of the cell. BCRP is capable of transporting non-chemotherapy drugs and xenobiotiocs as well, including nitrofurantoin, prazosin, glyburide, and 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine. BCRP is frequently detected at high levels in stem cells, likely providing xenobiotic protection. BCRP is also highly expressed in normal human tissues including the small intestine, liver, brain endothelium, and placenta. Therefore, BCRP has been increasingly recognized for its important role in the absorption, elimination, and tissue distribution of drugs and xenobiotics. At present, little is known about the transport mechanism of BCRP, particularly how it recognizes and transports a large number of structurally and chemically unrelated drugs and xenobiotics. Here, we review current knowledge of structure and function of this medically important ABC efflux drug transporter. Keywords: Breast cancer resistance protein, BCRP, ATP-binding cassette transporter, ABCG2, multidrug resistance, drug disposition, homology model, mutation analysis, BCRP/ABCG2, mitoxantrone-resistant human cancer cell lines, MXR, human placenta, ABCP, nucleotide binding domains, membrane spanning domains, MSDs, affinity constants, SAR, QSAR, flavonoids, tamoxifen analogues, cyclindependent kinase inhibitors, tariquidar analogues, FTC analogues, 2D-QSAR, CoMFA, CoMSIA, 3D-QSAR, MIFs, HEK cells, Pichia pastoris, Lactococcus lactis, fluorescence resonance energy transfer v, MODELLER
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., et al. (2009) · Science · doi:10.1126/science.1168750 · Cited by 1,929 · cited 3×
“This topology structure of BCRP was compared with that of mouse P-gp observed in crystal structures [94].”
BackgroundMethodInfluentialMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,386
Structure of a bacterial multidrug ABC transporter
Dawson, R. J. P., & Locher, K. P. (2006) · Nature · doi:10.1038/nature05155 · Cited by 1,279
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview
Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,231
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
The GxxxG motif: A framework for transmembrane helix-helix association
Russ, W. P., & Engelman, D. M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3489 · Cited by 936
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · Research at the University of Copenhagen (University of Copenhagen) · Cited by 929
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 916
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 813
Smith, P. C., Karpowich, N., Millen, L., Moody, J. E., Rosen, J., Thomas, P. J., & Hunt, J. F. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00576-2 · Cited by 773
Flexibility in the ABC transporter MsbA: Alternating access with a twist
Ward, A., Reyes, C. L., Yu, J., Roth, C. B., & Chang, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709388104 · Cited by 771
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Sarkadi, B., Homolya, L., Szakács, G., & Váradi, A. (2006) · Physiological Reviews · doi:10.1152/physrev.00037.2005 · Cited by 726
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout
Woodward, O. M., Köttgen, A., Coresh, J., Boerwinkle, E., Guggino, W. B., & Köttgen, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901249106 · Cited by 688
Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H., & Bates, S. E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2011 · Cited by 538
Zhou, S., Morris, J. J., Barnes, Y., Lan, L., Schuetz, J. D., & Sorrentino, B. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192276999 · Cited by 502
A Tweezers-like Motion of the ATP-Binding Cassette Dimer in an ABC Transport Cycle
Chen, J., Lu, G., Lin, J., Davidson, A. L., & Quiocho, F. A. (2003) · Molecular Cell · doi:10.1016/j.molcel.2003.08.004 · Cited by 490
Imai, Y., Nakane, M., Kage, K., Tsukahara, S., Ishikawa, E., Tsuruo, T., Miki, Y., & Sugimoto, Y. (2002) · PubMed · Cited by 475
Robey, R. W., To, K. K. K., Polgar, O., Dohse, M., Fetsch, P., Dean, M., & Bates, S. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.003 · Cited by 449
Honjo, Y., Hrycyna, C. A., Yan, Q. W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. C., & Bates, S. E. (2001) · PubMed · Cited by 429
Jonker, J. W., Merino, G., Musters, S., van Herwaarden, A. E., Bolscher, E., Wagenaar, E., Mesman, E., Dale, T. C., & Schinkel, A. H. (2005) · Nature Medicine · doi:10.1038/nm1186 · Cited by 423
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
Keskitalo, J. E., Zolk, O., Fromm, M. F., Kurkinen, K. J., Neuvonen, P. J., & Niemi, M. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.79 · Cited by 416
Role of the breast cancer resistance protein (ABCG2) in drug transport
Mao, Q. (2005) · The AAPS Journal · doi:10.1208/aapsj070112 · Cited by 405
Self-citationABCG2: determining its relevance in clinical drug resistance
Robey, R. W., Polgar, O., Deeken, J., To, K. W., & Bates, S. E. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9042-6 · Cited by 387
Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity
Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T. A., Runge, S., Risbood, M., Poruchynsky, M. S., & Bates, S. E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601370 · Cited by 368
ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 341
High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter
Özvegy-Laczka, C., Hegedűs, T., Várady, G., Ujhelly, O., Schuetz, J. D., Váradi, A., Kéri, G., Őrfi, L., Német, K., & Sarkadi, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.6.1485 · Cited by 340
Houghton, P. J., Germain, G. S., Harwood, F. C., Schuetz, J. D., Stewart, C. F., Buchdunger, E., & Traxler, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3344 · Cited by 323
Functional Characterization of the Human Multidrug Transporter, ABCG2, Expressed in Insect Cells
Özvegy, C., Litman, T., Szakács, G., Nagy, Z., Bates, S., Váradi, A., & Sarkadi, B. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5130 · Cited by 319
Chen, Z., Robey, R. W., Belinsky, M. G., Shchaveleva, I., Ren, X. Q., Sugimoto, Y., Ross, D. D., Bates, S. E., & Kruh, G. D. (2003) · PubMed · Cited by 305
Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR
de Bruin, M., Miyake, K., Litman, T., Robey, R., & Bates, S. E. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00182-2 · Cited by 298
Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10100 · Cited by 291
Imai, Y., Tsukahara, S., Asada, S., & Sugimoto, Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0078 · Cited by 280
Zamber, C. P., Lamba, J. K., Yasuda, K., Farnum, J., Thummel, K., Schuetz, J. D., & Schuetz, E. G. (2003) · Pharmacogenetics · doi:10.1097/00008571-200301000-00004 · Cited by 272
FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA
Kobayashi, D., Ieiri, I., Hirota, T., Takane, H., Maegawa, S., Kigawa, J., Suzuki, H., Nanba, E., Oshimura, M., Terakawa, N., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001628 · Cited by 268
Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2
Xu, J., Liu, Y., Yang, Y., Bates, S., & Zhang, J.-T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310785200 · Cited by 267
Kodaira, H., Kusuhara, H., Ushiki, J., Fuse, E., & Sugiyama, Y. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162321 · Cited by 266
Functional Analysis of SNPs Variants of BCRP/ABCG2
Kondo, C., Suzuki, H., Itoda, M., Ozawa, S., Sawada, J.-I., Kobayashi, D., Ieiri, I., Mine, K., Ohtsubo, K., & Sugiyama, Y. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045245.21637.d4 · Cited by 264
The role of transporters in cellular heme and porphyrin homeostasis
KRISHNAMURTHY, P., XIE, T., & SCHUETZ, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.001 · Cited by 260
Polli, J. W., Olson, K. L., Chism, J. P., John-Williams, L. S., Yeager, R. L., Woodard, S. M., Otto, V., Castellino, S., & Demby, V. E. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024646 · Cited by 256
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype*1
SPARREBOOM, A. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.03.003 · Cited by 241
Breast Cancer Resistance Protein Exports Sulfated Estrogens but Not Free Estrogens
Imai, Y., Asada, S., Tsukahara, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.610 · Cited by 235
Single nucleotide polymorphisms modify the transporter activity of ABCG2
Morisaki, K., Robey, R. W., Özvegy-Laczka, C., Honjo, Y., Polgar, O., Steadman, K., Sarkadi, B., & Bates, S. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0931-x · Cited by 230
van Herwaarden, A. E., Wagenaar, E., Merino, G., Jonker, J. W., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01621-06 · Cited by 226
Shukla, S., Robey, R. W., Bates, S. E., & Ambudkar, S. V. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024612 · Cited by 225
ABCG2: structure, function and role in drug response
Polgar, O., Robey, R. W., & Bates, S. E. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.1.1 · Cited by 224
Sequence motifs, polar interactions and conformational changes in helical membrane proteins
Curran, A. R., & Engelman, D. M. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00102-7 · Cited by 219
Dohse, M., Scharenberg, C., Shukla, S., Robey, R. W., Volkmann, T., Deeken, J. F., Brendel, C., Ambudkar, S. V., Neubauer, A., & Bates, S. E. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.031302 · Cited by 216
Özvegy, C., Váradi, A., & Sarkadi, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207857200 · Cited by 204
Ahmed-Belkacem, A., Pozza, A., Muñoz-Martínez, F., Bates, S. E., Castanys, S., Gamarro, F., Di Pietro, A., & Pérez-Victoria, J. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1817 · Cited by 196
Li, J., Cusatis, G., Brahmer, J., Sparreboom, A., Robey, R. W., Bates, S. E., Hidalgo, M., & Baker, S. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.3.3763 · Cited by 191
Wilson, C. S. (2006) · Blood · doi:10.1182/blood-2004-12-4633 · Cited by 190
Xie, Y., Xu, K., Linn, D. E., Yang, X., Guo, Z., Shimelis, H., Nakanishi, T., Ross, D. D., Chen, H., Fazli, L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707773200 · Cited by 189
Nakatomi, K., Yoshikawa, M., Oka, M., Ikegami, Y., Hayasaka, S., Sano, K., Shiozawa, K., Kawabata, S., Soda, H., Ishikawa, T., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5850 · Cited by 189
Breast Cancer Resistance Protein and P-Glycoprotein in 149 Adult Acute Myeloid Leukemias
Benderra, Z., Faussat, A.-M., Sayada, L., Perrot, J.-Y., Chaoui, D., Marie, J.-P., & Legrand, O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0795 · Cited by 188
Zhang, S., Yang, X., Coburn, R. A., & Morris, M. E. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.017 · Cited by 188
The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration
Huls, M., Russel, F. G. M., & Masereeuw, R. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132225 · Cited by 183
BCRP/ABCG2 in the Placenta: Expression, Function and Regulation
Mao, Q. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9537-z · Cited by 172
Self-citationABCG2: the key to chemoresistance in cancer stem cells?
An, Y., & Ongkeko, W. M. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903228834 · Cited by 170
Effect of ABCG2 genotype on the oral vioavailability of topotecan
Sparreboom, A., Loos, W. J., Burger, H., Sissung, T. M., Verweij, J., Figg, II, Nooter, K., & Gelderblom, H. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.6.1731 · Cited by 162
Furukawa, T., Wakabayashi, K., Tamura, A., Nakagawa, H., Morishima, Y., Osawa, Y., & Ishikawa, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9752-7 · Cited by 159
Purification and 3D Structural Analysis of Oligomeric Human Multidrug Transporter ABCG2
McDevitt, C. A., Collins, R. F., Conway, M. A., Modok, S., Storm, J., Kerr, I. D., Ford, R. C., & Callaghan, R. (2006) · Structure · doi:10.1016/j.str.2006.08.014 · Cited by 155
Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
Sissung, T. M., Baum, C. E., Kirkland, C. T., Gao, R., Gardner, E. R., & Figg, W. D. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9220-6 · Cited by 146
Matsson, P., Englund, G., Ahlin, G., Bergström, C. A. S., Norinder, U., & Artursson, P. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124768 · Cited by 143
Tamura, A., Watanabe, M., Saito, H., Nakagawa, H., Kamachi, T., Okura, I., & Ishikawa, T. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023556 · Cited by 141
Diop, N. K., & Hrycyna, C. A. (2005) · Biochemistry · doi:10.1021/bi0479858 · Cited by 136
Litman, T., Jensen, U., Hansen, A., Covitz, K.-M., Zhan, Z., Fetsch, P. A., Abati, A. D., Hansen, P. B., Horn, T. D., Skovsgaard, T., et al. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00492-3 · Cited by 131
Tamura, A., Wakabayashi, K., Onishi, Y., Takeda, M., Ikegami, Y., Sawada, S., Tsuji, M., Matsuda, Y., & Ishikawa, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2006.00371.x · Cited by 129
Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter
Clark, R., Kerr, I. D., & Callaghan, R. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706904 · Cited by 127
Grube, M., Reuther, S., zu Schwabedissen, H. E. M., Köck, K., Draber, K., Ritter, C. A., Fusch, C., Jedlitschky, G., & Kroemer, H. K. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.011411 · Cited by 126
MITOMO, H., KATO, R., ITO, A., KASAMATSU, S., IKEGAMI, Y., KII, I., KUDO, A., KOBATAKE, E., SUMINO, Y., & ISHIKAWA, T. (2003) · Biochemical Journal · doi:10.1042/bj20030150 · Cited by 122
Henriksen, U., Fog, J. U., Litman, T., & Gether, U. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502937200 · Cited by 119
The ATP-binding cassette family: a structural perspective
Kos, V. N., & Ford, R. C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0064-9 · Cited by 118
Mutational Analysis of ABCG2: Role of the GXXXG Motif
Polgár, O., Robey, R. W., Morisaki, K., Dean, M. C., Michejda, C. J., Sauna, Z. E., Ambudkar, S. V., Tarasova, N. I., & Bates, S. E. (2004) · Biochemistry · doi:10.1021/bi0497953 · Cited by 118
Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1)
Honjo, Y., Morisaki, K., Huff, L. M., Robey, R. W., Hung, J., Dean, M., & Bates, S. E. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.322 · Cited by 116
Sugimoto, Y., Tsukahara, S., Imai, Y., Sugimoto, Y., Ueda, K., & Tsuruo, T. (2003) · PubMed · Cited by 115
Katayama, K., Masuyama, K., Yoshioka, S., Hasegawa, H., Mitsuhashi, J., & Sugimoto, Y. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0426-7 · Cited by 114
Nakagawa, H., Wakabayashi‐Nakao, K., Tamura, A., Toyoda, Y., Koshiba, S., & Ishikawa, T. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07423.x · Cited by 113
Mao, Q., Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00150-9 · Cited by 111
Self-citationPál, Á., Méhn, D., Molnar, E. M., Gedey, S., Mészáros, P., Nagy, T., Glavinas, H., Janáky, T., von Richter, O., Báthori, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119289 · Cited by 107
Role of Cys‐603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2
Kage, K., Fujita, T., & Sugimoto, Y. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00126.x · Cited by 103
Shukla, S., Robey, R. W., Bates, S. E., & Ambudkar, S. V. (2006) · Biochemistry · doi:10.1021/bi060552f · Cited by 103
Structure–activity relationships of new inhibitors of breast cancer resistance protein (ABCG2)
Pick, A., Müller, H., & Wiese, M. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.034 · Cited by 100
Saito, H., Hirano, H., Nakagawa, H., Fukami, T., Oosumi, K., Murakami, K., Kimura, H., Kouchi, T., Konomi, M., Tao, E., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.099036 · Cited by 92
Özvegy‐Laczka, C., Várady, G., Köblös, G., Ujhelly, O., Cervenak, J., Schuetz, J. D., Sorrentino, B. P., Koomen, G., Váradi, A., Német, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411338200 · Cited by 92
Miwa, M., Tsukahara, S., Ishikawa, E., Asada, S., Imai, Y., & Sugimoto, Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.11484 · Cited by 91
Özvegy‐Laczka, C., Köblös, G., Sarkadi, B., & Váradi, A. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.11.005 · Cited by 90
Rosenberg, M. F., Bikádi, Z., Chan, J. Y. T., Liu, X., Ni, Z., Cai, X., Ford, R. C., & Mao, Q. (2010) · Structure · doi:10.1016/j.str.2010.01.017 · Cited by 90
Self-citationAhmed‐Belkacem, A., Pozza, A., Macalou, S., et al. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200603000-00001 · Cited by 86
Bhatia, A. K., Schäfer, H., & Hrycyna, C. A. (2005) · Biochemistry · doi:10.1021/bi0503807 · Cited by 86
Wakabayashi, K., Nakagawa, H., Tamura, A., Koshiba, S., Hoshijima, K., Komada, M., & Ishikawa, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700133200 · Cited by 83
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
Aller, S. G. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4143 · Cited by 81
Mohrmann, K., van Eijndhoven, M. A. J., Schinkel, A. H., & Schellens, J. H. M. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-1004-5 · Cited by 75
Tamura, A., Onishi, Y., An, R., Koshiba, S., Wakabayashi, K., Hoshijima, K., Priebe, W., Yoshida, T., Kometani, S., Matsubara, T., et al. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.428 · Cited by 72
QSAR analysis and molecular modeling of ABCG2-specific inhibitors
Nicolle, E., Boumendjel, A., Macalou, S., Genoux, E., Ahmed-Belkacem, A., Carrupt, P.-A., & Di Pietro, A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.10.004 · Cited by 71
Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
Hegedüs, C., Szakács, G., Homolya, L., Orbán, T. I., Telbisz, Á., Jani, M., & Sarkadi, B. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.007 · Cited by 71
Ejendal, K. F. K., Diop, N. K., Schweiger, L. C., & Hrycyna, C. A. (2006) · Protein Science · doi:10.1110/ps.051998406 · Cited by 69
Wakabayashi, K., Nakagawa, H., Adachi, T., Kii, I., Kobatake, E., Kudō, A., & Ishikawa, T. (2006) · PubMed · Cited by 67
Wang, H., Lee, E., Cai, X., Ni, Z., Zhou, L., & Mao, Q. (2008) · Biochemistry · doi:10.1021/bi801644v · Cited by 66
Self-citationGandhi, Y., & Morris, M. E. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9132-1 · Cited by 66
Alqawi, O., Bates, S. E., & Georges, E. (2004) · Biochemical Journal · doi:10.1042/bj20040355 · Cited by 61
Henriksen, U., Gether, U., & Litman, T. (2005) · Journal of Cell Science · doi:10.1242/jcs.01729 · Cited by 61
Pollex, E. K., Anger, G. J., Hutson, J. R., Koren, G., & Piquette‐Miller, M. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030791 · Cited by 60
Arimori, K., Kuroki, N., Hidaka, M., Iwakiri, T., Yamasaki, K., Okumura, M., Ono, H., Takamura, N., Kikuchi, M., & Nakano, M. (2003) · Pharmaceutical Research · doi:10.1023/a:1023847521767 · Cited by 59
Ishikawa, T., Tamura, A., Saito, H., Wakabayashi, K., & Nakagawa, H. (2005) · Die Naturwissenschaften · doi:10.1007/s00114-005-0019-4 · Cited by 57
Tamaki, H., Satoh, H., Hori, S., Ohtani, H., & Sawada, Y. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.170 · Cited by 53
Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics.
Ishikawa, T., & Nakagawa, H. (2009) · PubMed · Cited by 48
Vethanayagam, R. R., Wang, H., Gupta, A., Zhang, Y., Lewis, F. M., Unadkat, J. D., & Mao, Q. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003657 · Cited by 47
Self-citationNicolle, E., Boccard, J., Guilet, D., Dijoux-Franca, M.-G., Zelefac, F., Macalou, S., Grosselin, J., Schmidt, J., Carrupt, P.-A., Di Pietro, A., et al. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.05.012 · Cited by 47
Is ATP binding responsible for initiating drug translocation by the multidrug transporter ABCG2?
McDevitt, C. A., Crowley, E. H., Hobbs, G., Starr, K. J., Kerr, I. D., & Callaghan, R. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06578.x · Cited by 46
Özvegy‐Laczka, C., Laczkó, R., Hegedüs, C., Litman, T., Várady, G., Goda, K., Hegedűs, T., Dokholyan, N. V., Sorrentino, B. P., Váradi, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803230200 · Cited by 43
Polgár, O., Ieranò, C., Tamaki, A., Stanley, B. J., Ward, Y., Xia, D., Tarasova, N. I., Robey, R. W., & Bates, S. E. (2010) · Biochemistry · doi:10.1021/bi902085q · Cited by 42
Mutational Studies of G553 in TM5 of ABCG2: A Residue Potentially Involved in Dimerization
Polgár, O., Özvegy‐Laczka, C., Robey, R. W., Morisaki, K., Okada, M., Tamaki, A., Köblös, G., Elkind, N. B., Ward, Y., Dean, M. C., et al. (2006) · Biochemistry · doi:10.1021/bi0521590 · Cited by 40
Purification and structural analyses of ABCG2
McDevitt, C. A., Collins, R. F., Kerr, I. D., & Callaghan, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.07.004 · Cited by 39
Effect of Cysteine Mutagenesis on the Function and Disulfide Bond Formation of Human ABCG2
Liu, Y., Yang, Y., Qi, J. W., Peng, H., & Zhang, J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138115 · Cited by 37
Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells
Ishikawa, T., Kasamatsu, S., Hagiwara, Y., Mitomo, H., Kato, R., & Sumino, Y. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.194 · Cited by 36
Mo, W., & Zhang, J. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903124371 · Cited by 35
Functional expression of the human breast cancer resistance protein in Pichia pastoris
Mao, Q., Conseil, G., Gupta, A., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.012 · Cited by 35
Self-citationCai, X., Bikádi, Z., Ni, Z., Lee, E., Wang, H., Rosenberg, M. F., & Mao, Q. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163493 · Cited by 35
Self-citationAn, R., Hagiya, Y., Tamura, A., Li, S., Saito, H., Tokushima, D., & Ishikawa, T. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9738-5 · Cited by 34
Ni, Z., Mark, M. E., Cai, X., & Mao, Q. (2010) · PubMed Central · Cited by 32
Self-citationArginine 383 is a crucial residue in ABCG2 biogenesis
Polgár, O., Ediriwickrema, L. S., Robey, R. W., Sharma, A., Hegde, R. S., Li, Y., Xia, D., Ward, Y., Dean, M. C., Özvegy‐Laczka, C., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.04.016 · Cited by 28
Effects of Putative Catalytic Base Mutation E211Q on ABCG2-Mediated Methotrexate Transport
Hou, Y.-X., Li, C.-Z., Palaniyandi, K., Magtibay, P. M., Homolya, L., Sarkadi, B., & Chang, X.-B. (2009) · Biochemistry · doi:10.1021/bi900675v · Cited by 16
Saito, H., An, R., Hirano, H., & Ishikawa, T. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.72 · Cited by 7
Polgár, O., Deeken, J. F., Ediriwickrema, L. S., Tamaki, A., Steinberg, S. M., Robey, R. W., & Bates, S. E. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9940-0 · Cited by 6
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Blood–brain barrier structure and function and the challenges for CNS drug delivery
Abbott, N. J. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-013-9608-0 · Cited by 909
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
Mao, Q., & Unadkat, J. D. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9668-6 · Cited by 670
Self-citationMolecular mechanisms of drug resistance and its reversal in cancer
Kartal-Yandim, M., Adan-Gokbulut, A., & Baran, Y. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1015957 · Cited by 346
Intestinal drug transporters: An overview
Estudante, M., Morais, J. G., Soveral, G., & Benet, L. Z. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.042 · Cited by 330
Metadata
- Authors
- Ni, Z., Bikadi, Z., F. Rosenberg, M., & Mao, Q.
- Venue
- Current Drug Metabolism
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-09-01
- Volume
- 11
- Issue
- 7
- Pages
- 603-617
- ISSN
- 1389-2002 (ISSN-L)
- OpenAlex
- W2137683119
- Cited by
- 277
- References
- 127
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.